These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33027633)

  • 1. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach.
    Zhang J; Thakkar R; Zhang Y; Maniruzzaman M
    Int J Pharm; 2020 Nov; 590():119945. PubMed ID: 33027633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
    Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
    AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
    Obeid S; Madžarević M; Ibrić S
    Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
    Than YM; Titapiwatanakun V
    Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
    Chung S; Zhang P; Repka MA
    Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Xu P; Chung S; Bandari S; Repka MA
    Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses.
    Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I
    Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
    Dos Santos J; Deon M; da Silva GS; Beck RCR
    Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
    Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
    Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drug release from diazepam FDM printed tablets using deep learning approach: Influence of process parameters and tablet surface/volume ratio.
    Obeid S; Madžarević M; Krkobabić M; Ibrić S
    Int J Pharm; 2021 May; 601():120507. PubMed ID: 33766640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool.
    Thakkar R; Pillai AR; Zhang J; Zhang Y; Kulkarni V; Maniruzzaman M
    Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the Fused Deposition Modeling Additive Manufacturing I: Influence of Process Temperature on the Quality and Crystallinity of the Dosage Forms.
    Zhang J; Thakkar R; Kulkarni VR; Zhang Y; Lu A; Maniruzzaman M
    AAPS PharmSciTech; 2021 Oct; 22(8):258. PubMed ID: 34697652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.